Gene: PSMD10
Official Full Name: proteasome 26S subunit, non-ATPase 10provided by HGNC
Gene Summary: This gene encodes a subunit of the PA700/19S complex, which is the regulatory component of the 26S proteasome. The 26S proteosome complex is required for ubiquitin-dependent protein degradation. This protein is a non-ATPase subunit that may be involved in protein-protein interactions. Aberrant expression of this gene may paly a role in tumorigenesis. Two transcripts encoding different isoforms have been described. Pseudogenes have been identified on chromosomes 3 and 20.[provided by RefSeq, Mar 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03963 | PSMD10 Knockout cell line (HeLa) | Human | PSMD10 | 1:3~1:6 | Negative | Online Inquiry |
KO03964 | PSMD10 Knockout cell line (HCT 116) | Human | PSMD10 | 1:2~1:4 | Negative | Online Inquiry |
KO03965 | PSMD10 Knockout cell line (HEK293) | Human | PSMD10 | 1:3~1:6 | Negative | Online Inquiry |
KO03966 | PSMD10 Knockout cell line (A549) | Human | PSMD10 | 1:3~1:4 | Negative | Online Inquiry |
PSMD10 Gene Knockout Cell Lines are advanced biological research tools designed to facilitate the study of the PSMD10 gene’s role in cellular functions and its implications in various diseases, including cancer and neurodegenerative disorders. These cell lines have been engineered through CRISPR-Cas9 technology to precisely disrupt the PSMD10 gene, enabling researchers to investigate the effects of its absence in a controlled environment.
The key mechanism behind these knockout cell lines involves the targeted editing of the PSMD10 gene, which encodes a subunit of the 26S proteasome, integral to protein degradation and regulation of numerous signaling pathways. By knocking out this gene, researchers can elucidate the pathways impacted by disruptors of proteasomal function, leading to insights into cellular physiology and pathology. The PSMD10 knockout model is crucial for experiments that require understanding the gene's contribution to tumorigenesis, drug resistance, and cellular stress responses.
From a scientific standpoint, the availability of PSMD10 Gene Knockout Cell Lines significantly enhances investigative capacities in both research and clinical settings by providing a reliable system for functional assays, drug screening, and biomarker validation. Compared to other models, including complete animal studies or less specific RNA interference approaches, these knockout lines offer a more precise and ethically viable alternative that can yield reproducible and quantifiable results.
The unique advantages of utilizing PSMD10 knockout cell lines include their customization to various cancer types, compatibility with high-throughput screening technologies, and the ability to examine compensatory biological responses post-knockout. For researchers and clinicians alike, this tool is invaluable in accelerating the development of novel therapeutic strategies and improving our understanding of disease mechanisms.
Our company specializes in supplying high-quality biological products designed for cutting-edge research applications. With a commitment to innovation and scientific excellence, we provide resources that empower scientists to make groundbreaking discoveries in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.